§ Federal grant opportunity · PAR-25-113
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
National Institutes of Health is accepting applications for Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed). The deadline is September 7, 2027 and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- September 7, 2027
- Award range
- Award amount not published
- Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Geography
- United States
- Focus areas
- Health, Human Services
- Opportunity number
- PAR-25-113
Program overview
The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before September 7, 2027, allowing time for registration and validation.
Related grant opportunities
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
- Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
- Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
- Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
- FAA Aviation Research Grants Program
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.